You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沛嘉醫療-B(09996.HK):Edwards Lifesciences擬以合併方式收購JenaValve
格隆匯 07-26 07:56

格隆匯7月26日丨沛嘉醫療-B(09996.HK)發佈公吿,公司的全資附屬公司Marvel Finder Limited持有JenaValve股本約1.91%(按悉數攤薄及轉換基準計算)的少數股東權益,該權益於公司綜合財務報表中記錄為按公允值計入損益的金融資產。JenaValve已通知公司,於2024年7月23日(美國時間), Edwards Lifesciences(通過其全資附屬公司)已同意以合併方式收購JenaValve。緊隨完成後,公司將不再持有JenaValve的任何股權。合併協議規定,於完成時預付5億美元,惟須根據慣例進行調整,或有代價最高為4.45億美元。

董事認為,合併事項將使集團能夠兑現自投資以來一段時間內累積的對JenaValve的投資價值,且為增強集團目前時點財務靈活性的機會。集團擬將合併事項所得款項用於補充集團的營運資金,以支持集團在研候選藥物的成長與發展。合併事項表明對利用JenaValve技術治療AR的未來前景充滿信心。JenaValve將能夠利用Edwards的專業知識。公司預計合併事項將增強JenaValve技術的競爭力。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account